Cargando…
Doxofylline for Pediatric Asthma Steps 1–4. Pediatric Asthma: New Role for an Old Drug
The panoply of anti-asthma drugs for children between 6 and 18 years is not limited to those reported in the guidelines. In this review, we will re-assess the role of doxofylline, a xanthine characterized by a much higher handling than that of theophylline, as add-on treatment in pediatric asthma gr...
Autores principales: | Fierro, Vincenzo, Piscitelli, Anna Lucia, Battaglia, Edda, Fiocchi, Alessandro |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9256910/ https://www.ncbi.nlm.nih.gov/pubmed/35813377 http://dx.doi.org/10.3389/fped.2022.772704 |
Ejemplares similares
-
Severe Asthma and Allergy: A Pediatric Perspective
por: Arasi, Stefania, et al.
Publicado: (2019) -
New Drugs for Pediatric Asthma
por: Maglione, Marco, et al.
Publicado: (2019) -
Do not forget asthma comorbidities in pediatric severe asthma!
por: Ronco, Lucia, et al.
Publicado: (2022) -
The Burden of Pediatric Asthma
por: Ferrante, Giuliana, et al.
Publicado: (2018) -
Immunomodulation in Pediatric Asthma
por: Licari, Amelia, et al.
Publicado: (2019)